2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Enteropathy Associated T-cell Lymphoma: new trials by email Literature Review of Enteropathy Associated T-cell Lymphoma trials Research Report on Enteropathy Associated T-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1. Brentuximab Vedotin - Enteropathy Associated T-cell Lymphoma | Phase 2 | Completed | Imagine Institute | 14 | 2018-02-07 | 2024-06-20 |
| A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) Brentuximab vedotin - T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma | Phase 2 | Completed | Deepa Jagadeesh | 23 | 2016-06-17 | 2025-11-21 |
Enteropathy-Associated T-Cell Lymphoma (2) · Immunoblastic Lymphadenopathy (1) · Leukemia (1) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, T-Cell (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Hematologic Diseases (1) · Leukemia, Lymphoid (1) · Lymphadenopathy (1) · Lymphoma (1) · Lymphoma, T-Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Deepa Jagadeesh (1) · Imagine Institute (1)
France (1) · United States (1)
Deepa Jagadeesh, MD, MPH (1) · Hermine Olivier (1) · Paolo Caimi, MD (1)